FADS1 and aortic valve stenosis: Direct therapeutic alteration of FADS1/2 expression, to mimic the observed genetic effects and reduce fatty acid desaturation, may represent a therapeutic strategy for AS, which is supported by the results of our mendelian randomization of FADS1 expression.